Reprint This Article

Pharma Companies Argue That Lower Drug Prices Would Mean Fewer Breakthrough Drugs. Is That True?

Probably not, a new study suggests—as long as the price decreases are modest.

David Dranove, Craig Garthwaite and Manuel I. Hermosilla

If you are interested in reprinting this article, please contact us for permission, guidelines, code, and a canonical link. There is no fee for reprinting an article.

Request reprint code
for "Pharma Companies Argue That Lower Drug Prices Would Mean Fewer Breakthrough Drugs. Is That True?"

About Us Faculty & Research Research Hub

2211 Campus Drive, Evanston, IL 60208

insight@kellogg.northwestern.edu

Substack

RSS